KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Lam Research (LRCX) EBT Margin (2016 - 2026)

Lam Research has reported EBT Margin over the past 18 years, most recently at 34.44% for Q1 2026.

  • For Q1 2026, EBT Margin rose 188.0% year-over-year to 34.44%; the TTM value through Mar 2026 reached 34.53%, up 340.0%, while the annual FY2025 figure was 32.32%, 307.0% up from the prior year.
  • EBT Margin for Q1 2026 was 34.44% at Lam Research, roughly flat from 34.36% in the prior quarter.
  • Over five years, EBT Margin peaked at 34.92% in Q3 2025 and troughed at 24.26% in Q1 2023.
  • A 5-year average of 30.7% and a median of 30.81% in 2024 define the central range for EBT Margin.
  • Biggest five-year swings in EBT Margin: tumbled -368bps in 2023 and later surged 458bps in 2025.
  • Year by year, EBT Margin stood at 31.3% in 2022, then fell by -8bps to 28.92% in 2023, then grew by 7bps to 30.81% in 2024, then grew by 12bps to 34.36% in 2025, then grew by 0bps to 34.44% in 2026.
  • Business Quant data shows EBT Margin for LRCX at 34.44% in Q1 2026, 34.36% in Q4 2025, and 34.92% in Q3 2025.